PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21328456-6	2011	ODQ (1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one), which blocks endogenous NO-induced activation of sGC and thus lowers endogenous cGMP/PKG activity, significantly elevated apoptotic levels by 2.5- and three-fold.	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	5-49	protein kinase cGMP-dependent 1	Homo sapiens	137-140	
23006734-3	2012	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) blockade of cGMP production increased disulfide PKG to 13 +- 2% and 29+-4% of total in aorta and mesenteries, respectively.	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	0-43	protein kinase cGMP-dependent 1	Homo sapiens	98-101	
23006734-3	2012	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) blockade of cGMP production increased disulfide PKG to 13 +- 2% and 29+-4% of total in aorta and mesenteries, respectively.	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	45-48	protein kinase cGMP-dependent 1	Homo sapiens	98-101	
23006734-8	2012	Why aorta treated with ODQ generated less PKG disulfide that is insufficient to induce vasoconstriction was unclear.	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	23-26	protein kinase cGMP-dependent 1	Homo sapiens	42-45	
15878941-4	2005	After ARVM were exposed to IL-6 for 2-24 h, intracellular cGMP contents were time dependently increased; this was mimicked by a NO donor and abolished by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), an inhibitor of soluble guanylyl cyclase (sGC), or Rp-8-Br-cGMP, an inhibitor of cGMP-dependent protein kinase G (PKG).	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	154-197	protein kinase cGMP-dependent 1	Homo sapiens	319-322	
26984419-6	2016	Additionally, this inhibitory effect of GSNO on KNa channel activity was diminished by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), an inhibitor of soluble guanylate cyclase (sGC), and KT5823, an inhibitor of protein kinase G (PKG).	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	87-130	protein kinase cGMP-dependent 1	Homo sapiens	233-236	
26984419-6	2016	Additionally, this inhibitory effect of GSNO on KNa channel activity was diminished by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), an inhibitor of soluble guanylate cyclase (sGC), and KT5823, an inhibitor of protein kinase G (PKG).	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	132-135	protein kinase cGMP-dependent 1	Homo sapiens	215-231	
26984419-6	2016	Additionally, this inhibitory effect of GSNO on KNa channel activity was diminished by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), an inhibitor of soluble guanylate cyclase (sGC), and KT5823, an inhibitor of protein kinase G (PKG).	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	132-135	protein kinase cGMP-dependent 1	Homo sapiens	233-236